Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358020
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2006-07-27
Brief Title:
Melphalan Prednisone Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
Sponsor:
University of Turin Italy
Organization:
University of Turin Italy
Organization Data
Organization:
University of Turin Italy
Class:
OTHER
Study ID:
X05141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Turin Italy
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None